Lisa Jarvis In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their body weight, on average, a result that caused the Danish ...
Ozempic has gotten most of the name recognition associated with weight-loss drugs, it's not the only drug in this category ...
The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.
Both companies are longtime leaders in the pharmaceutical industry and have been making breakthroughs and delivering ...
Although Novo will still make a mind-blowing amount of money from its existing obesity drugs in the coming years (its ...
Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...
By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 500.39% and ...
A specific class of anti-inflammatory drugs can help children avoid a debilitating complication of Crohn's disease, a new study shows.
The U.S. Food and Drug Administration (FDA) has proposed a new rule to require standardized testing of talc-containing ...
Research backs this up: Young men who consumed more protein while losing weight and on an intense exercise regiment gained ...
Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback